Current NDC auxiliary source row compounder:11

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71449-125
Product Ndc: 71449-125
Product Ndc Digits: 71449125
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Neostigmine Methylsulfate
Proprietary Name Suffix: Preservative Free
Nonproprietary Name: Neostigmine Methylsulfate
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Denver Solutions, LLC dba Leiters Health
Establishment Name: Denver Solutions, LLC dba Leiters Health
Establishment Fei: [empty]
Substance Name: NEOSTIGMINE METHYLSULFATE
Active Ingredients Info: 1 mg/1 mL
History Active Ingredients Raw: NEOSTIGMINE METHYLSULFATE
History Active Ingredients Info Raw: 1 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 71449-125-11
Package Ndc: 71449-125-11
Package Ndc Digits: 7144912511
Package Ndc11: 71449012511
Package Description: 5 SYRINGE, PLASTIC in 1 CONTAINER (71449-125-11) > 5 mL in 1 SYRINGE, PLASTIC
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:11
Source Row Number: 11
Source Row Hash: e0c69c6bf5a1a6905c8dda6a5b22bdab6e702f56a6d654e52fe5d945380eaeb1
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "71449-125",
    "DEASCHEDULE": "",
    "LABELERNAME": "Denver Solutions, LLC dba Leiters Health",
    "SUBSTANCENAME": "NEOSTIGMINE METHYLSULFATE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "71449-125-11",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Neostigmine Methylsulfate",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Neostigmine Methylsulfate",
    "PACKAGEDESCRIPTION": "5 SYRINGE, PLASTIC in 1 CONTAINER (71449-125-11)  > 5 mL in 1 SYRINGE, PLASTIC",
    "ACTIVEINGREDIENTSINFO": "1 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": "Preservative Free"
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:11
Source Row Number: 11
Status Scope: package
Lookup Ndc: 71449-125-11
Lookup Ndc Digits: 7144912511
Product Ndc: 71449-125
Product Ndc Digits: 71449125
Package Ndc: 71449-125-11
Package Ndc Digits: 7144912511
Package Ndc11: 71449012511
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: e0c69c6bf5a1a6905c8dda6a5b22bdab6e702f56a6d654e52fe5d945380eaeb1
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51